Private equity giant KKR is reportedly closing in on a deal to acquire Integer Holdings, a manufacturer of components for medical devices. According to The Wall Street Journal, KKR could offer $127 per share, valuing the company at roughly $4.3 billion. The report suggests an offer could come as soon as next week.
Integer shares jumped more than 20% on the news, reflecting the premium the reported bid would represent over the company's recent market value. Before the report, Integer was valued at about $3.42 billion, according to LSEG data.
Why Integer is in play
Integer, based in Plano, Texas, designs and assembles the intricate components that go into medical devices—everything from catheters and pacemakers to surgical instruments. The company doesn't sell directly to patients; instead, it works behind the scenes for larger medical device makers, making it a key link in the healthcare supply chain.
The company put itself up for sale in April when it announced a "strategic review" after receiving interest from potential buyers. In such reviews, companies often explore a range of options, including a sale, merger, or other strategic moves. The fact that Integer is now reportedly in talks with KKR suggests the process is moving toward a concrete outcome.
KKR is one of the world's largest private equity firms, with a long history of acquiring companies across industries, including healthcare. A takeover of Integer would fit a pattern of private equity firms targeting specialized manufacturers with steady cash flows and strong positions in their niches.
What a $127 offer means for investors
For Integer shareholders, the reported offer price is the headline number. At $127 per share, the bid would be a significant premium to where the stock traded before the news. That premium is why the shares rallied sharply—investors are pricing in a high likelihood that a deal gets done at or near that level.
But a reported offer is not a done deal. Talks could still fall apart, or another bidder could emerge. In situations like this, investors often watch for official announcements from the companies involved, as well as any regulatory hurdles that might arise.
For everyday investors, the key takeaway is that M&A activity can create sudden, large moves in a stock. When a company is acquired, shareholders typically receive a cash payment or shares in the acquirer. In this case, if the deal goes through at $127, Integer shareholders would likely receive cash for their shares, and the stock would stop trading.
It's also worth noting that private equity takeovers often involve the buyer taking on debt to finance the purchase. That can put pressure on the acquired company to cut costs or increase efficiency to service that debt. For Integer's customers—medical device makers—a change in ownership could mean changes in pricing or supply arrangements, though such impacts are usually not immediate.
Broader context: A busy stretch for deals
The reported Integer talks come amid a broader wave of M&A activity. Private equity firms have been active across sectors, from Couche-Tard's $8.7 billion tender offer for Poland's Zabka to EQT's £10.9 billion buyout of Intertek. Healthcare and medical technology have been particularly busy areas, as investors seek companies with durable demand and growth potential.
For Integer, the strategic review was prompted by inbound interest, which often signals that a company's assets are seen as undervalued or strategically attractive. Medical device outsourcing is a growing field, as larger manufacturers increasingly rely on specialized partners to keep costs down and speed up innovation.
What to watch next
Investors should keep an eye on official statements from Integer and KKR. If a deal is announced, the terms will be laid out in detail, including any conditions or regulatory approvals required. The timing of the deal's completion could also affect when shareholders receive payment.
There's also the possibility that another buyer could step in with a higher offer, a scenario that sometimes plays out in contested takeovers. But for now, the market seems to be betting that KKR's reported bid will succeed.
For those who don't own Integer shares, the story is a reminder of how M&A can create opportunities—and risks—in the stock market. While a takeover premium can be a windfall for existing shareholders, it also means the stock's future is tied to the deal's outcome, which can be uncertain until the ink is dry.
